AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

12,474.00p
   
  • Change Today:
    -90.00p
  • 52 Week High: 12,940.00p
  • 52 Week Low: 9,667.00p
  • Currency: UK Pounds
  • Shares Issued: 1,550.70m
  • Volume: 1,355,555
  • Market Cap: £193,435m
  • RiskGrade: 123

Key dates

Dividend  
Latest XD Date (1st Interim) 07-Aug-2025
Latest Pay Date (1st Interim) 08-Sep-2025
   
Meetings  
AGM 11-Apr-2025
EGM n/a
GMs n/a
   
Announcements  
Trading announcement n/a
IMSs n/a
Drilling Report n/a
   
Results  
Final results 10-Feb-2026
Interim results 29-Jul-2025
Q1 Results 29-Apr-2025
Q2 Results 29-Jul-2025
Q3 Results 06-Nov-2025
Q4 Results 10-Feb-2026
Annual Report 18-Feb-2025
   
Year End 31-Dec-2025

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

AstraZeneca Market Data

Currency UK Pounds
Share Price 12,474.00p
Change Today -90.00p
% Change -0.72 %
52 Week High 12,940.00p
52 Week Low 9,667.00p
Volume 1,355,555
Shares Issued 1,550.70m
Market Cap £193,435m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average
90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average
Price Trend
9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Income
68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 9
Buy 13
Neutral 4
Sell 0
Strong Sell 1
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 07-Aug-25 20-Feb-25
Paid 08-Sep-25 24-Mar-25
Amount 103.00¢ 210.00¢

Trades for 21-Oct-2025

Time Volume / Share Price
16:28 0 @ 12,482.00p
16:17 2 @ 12,494.00p
16:18 0 @ 12,492.00p
16:11 0 @ 12,484.00p
16:25 2 @ 12,484.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page